VENOUS

Vancomycin-resistant ENterococci OUtcomes Study

TITLE

Prospective Evaluation of Clinical Outcomes of Cancer Patients with Vancomycin-Resistant Enterococcus faecium (VRE) Bacteremia

DESCRIPTION
Prospective study in cancer patients 18 years of age and older to evaluate the outcomes of patients with Vancomycin-Resistant Enterococcus faecium (VRE) bloodstream infections (BSIs) treated with Daptomycin (DAP) to compare clinical outcomes stratifying by minimum inhibitory concentration (MIC).

CEF_BP

Ceftriaxone Breakpoint

TITLE

Multi-center gram negative database to establish clinically relevant antibiotic breakpoint interpretive criteria for Ceftriaxone

DESCRIPTION
A retrospective, observational propensity score-matched study of patients 18 years or older with monomicrobial Gram-negative bacteremia with the primary objective being:
to compare clinical outcomes of adult patients with Gram-negative bacteremia with organisms with minimum inhibitory concentrations between 4-8 µg/ml who received ceftriaxone compared with broader-spectrum antibiotic agents